Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Patent
1998-06-19
2000-11-28
McKelvey, Terry
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
530324, 530350, 536 231, C07K 1447, C07H 2100
Patent
active
061537292
ABSTRACT:
Nuclear matrix targeting peptides (NMTPs) capable of delivering a variety of therapeutic and diagnostic agents, such as transcription regulatory factors, to the nuclear matrix of a cell are disclosed.
REFERENCES:
patent: 5580727 (1996-12-01), Ohki et al.
Berendsen, Science, vol. 282: pp. 642-643, Oct. 1998.
van Wijnen, A.J. et al. "Developmental Control of Trans-activation and Subnuclear Location in Osteoblasts: Identification of a Nuclear Matrix Targeting Domain in the AML-1/CBF-.alpha./RUNT Transcription Factor" Journal of Bone and Mineral Research 11(Supp. 1):S393 (1996).
Zeng, C. et al., "Identification of a Nuclear Matrix Targeting Signal in the Leukemia and Bone-related AML/CBF-.alpha. Transcription Factors" Proc. Natl. Acad. Sci. USA 94:6746-6751 (1997).
Bae, S.C. et al., "Isolation of PEB2.alpha.B cDNA Representing the Mouse Homolog of Human Acute Myeloid Leukemia Gene AML1," Oncogene, vol. 8, No. 3, 809-14 (1993).
Banerjee, C. et al., "An AML-1 Consensus Sequence Binds an Osteoblast-Specific Complex and Transcriptionally Activates the Osteocalcin Gene," PNAS, vol. 93, 4968-73 (1996).
Berger, J. et al., "Secreted Placental Alkaline Phosphatase: a Powerful New Quantitative Indicator of gene Expression in Eukaryotic Cells," Gene, vol. 66, 1-10 (1988).
Bidwell, J. et al., "Osteocalcin Gene Promoter-binding Factors are Tissue-specific Nuclear Matrix Components," PNAS, vol. 90, 3162-6 (1993).
Blencowe, B.J. et al., "Association of Nuclear Matrix Antigens with Exon-Containing Splicing Complexes," J. Cell Biol., vol. 127, 593-607 (1994).
Brown, C.J. et al., "The Human XIST Gene: Analysis of a 17 kb Inactive X-Specific RNA That Contains Conserved Repeats and is Highly Localized within the Nucleus," Cell, vol. 71, 527-42 (1992).
Buhrmester, H. et al., "Nuclear Matrix Protein ARBP Recognizes a Novel DNA Sequence Motif with High Affinity," Biochemistry, vol. 34, 4108-17 (1995).
Carter, K.C. et al., "A Three-Dimensional View of Precursor Messenger RNA Metabolism Within the Mammalian Nucleus," Science, vol. 259, 1330-5 (1993).
Carvalho, T. et al., "Targeting of Adenovirus E1A and E4-ORF3 Proteins to Nuclear Matrix-associated PML Bodies," J. Cell. Biol., vol. 131, 45-56 (1995).
Clemson, C.M. et al., "XIST RNA Paints the Inactive X Chromosome at Interphase: Evidence for a Novel RNA Involved in Nuclear/Chromosome Structure," J. Cell Biol., vol. 132, 259-75 (1996).
Dickinson, L.A. et al., "A Tissue-Specific MAR/SAR DNA-Binding Protein with Unusual Binding Site Recognition," Cell, vol. 70, 631-45 (1992).
Downing, J.R. et al., "An AML1/ETO Fusion Transcript is Consistently Detected by RNA-Based Polymerase Chain Reaction in Acute Myelogenous Leukemia Containing the (8;21)(q22;q22) Translocation," Blood, vol. 81, No. 11, 2860-5 (1993).
Dyck, J.A. et al., "A Novel Macromolecular Structure is a Target of the Promyelocyte-Retinoic Acid Receptor Oncoprotein," Cell, vol. 76, 333-43 (1994).
Erickson, P. et al., "Identification of Breakpoints in t(8;21) Acute Myelogenous Leukemia and Isolation of a Fusion Transcript, AML1/ETO, with Similarity to Drosophila Segmentation Gene, runt," Blood, vol. 80, No. 7, 1825-31 (1992).
Fakan, S., "Perichromatin Fibrils are in situ Forms of Nascent Transcripts," Trends Cell Biol., vol. 4, 86-90 (1994).
Fey, E.G. et al., "Epithelial Cytoskeletal Framework and Nuclear Matrix-Intermediate Filament Scaffold: Three-dimensional Organization and Protein Composition," J. Cell. Biol., vol. 98, 1973-84 (1984).
Frank, R. et al., "The AML1/ETO Fusion Protein Blocks Transactivation of the GM-CSF Promoter by AML1B," Oncogene, vol. 11, 2667-74 (1995).
Giese, K. et al., "Assembly and Function of a TCR.alpha. Enhancer Complex is Dependent on LEF-1-induced DNA Bending and Multiple Protein-Protein Interactions," Genes Dev., vol. 9, 995-1008 (1995).
Golub, T.R. et al., "Fusion of the TEL Gene on 12p13 to the AML1 Gene on 21q22 in Acute Lymphoblastic Leukemia," PNAS, vol. 92, 4917-21 (1995).
Gottschalk, L.R. and Leiden, J.M., "Identification and Functional Characterization of the Human T-Cell Receptor .beta. Gene Transcriptional Enhancer: Common Nuclear Proteins Interact with the Transcriptional Regulatory Elements of the T-Cell Receptor .alpha. and .beta. Genes," Mol. Cell. Biol., vol. 10, No. 10, 5486-95 (1990).
Guo, B. et al., "The Nuclear Matrix Protein NMP-1 is the Transcription Factor YY1," PNAS, vol. 92, 10526-30 (1995).
Hernandez-Munain, C. and Krangel, M.S., "Regulation of the T-Cell Receptor .delta. Enhancer by Functional Cooperation Between c-Myb and Core-Binding Factors," Mol. Cell. Biol., vol. 14, No. 1, 473-83 (1994).
Hiebert, S.W. et al., "The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription," Mol. Cell. Biol., vol. 16, No. 4, 1349-55 (1996).
Ho, I.-C. et al., "A T-Cell-Specific Transcriptional Enhancer Element 3' of C.alpha. in the Human T-Cell Receptor .alpha. Locus," PNAS, vol. 86, 6714-8 (1989).
Kurokawa, M. et al., "A Conserved Cysteine Residue in the runt Homology Domain of AML1 is Required for the DNA Binding Ability and the Transforming Activity on Fibroblasts," J. Biol. Chem., vol. 271, No. 28, 16870-6 (1996).
Lenny, N. et al., "Functional Domains of the t(8;21) Fusion Protein, AML-1/ETO," Oncogene, vol. 11, 1761-9 (1995).
Lenny, N. et al., "The AML Family of Transcription Factors Associates with the Nuclear Matrix and this Association is Necessary for Transcriptional Activation," Blood, vol. 86, No. 10, 2375 (1995).
Leonhardt, H. et al., "A Targeting Sequence Directs DNA Methyltransferase to Sites of DNA Replication in Mammalian Nuclei," Cell, vol. 71, 865-73 (1992).
Levanon, D. et al., "AML1, AML2, and AML3, the Human Members of the runt domain Gene-Family: cDNA Structure, Expression, and Chromosomal Localization," Genomics, vol. 23, 425-32 (1994).
Lu, J. et al., "Subcellular Localization of the .alpha. and .beta. Subunits of the Acute Myeloid Leukemia-Linked Transcription Factor PEBP2/CBF," Molecular and Cellular Biology, vol. 15, No. 1651-61 (1995).
Luderus, M.E.E. et al., "Binding of Matrix Attachment Regions to Lamin B1," Cell, vol. 70, 949-59 (1992).
Luderus, M.E.E. et al., "Binding of Matrix Attachment Regions to Lamin Polymers Involves Single-Stranded Regions and the Minor Groove," Mol. Cell. Biol., vol. 14, No. 9, 6297-6305 (1994).
Mancini, M.A. et al., "The Retinoblastoma Gene Product is a Cell Cycle-Dependent, Nuclear Matrix-Associated Protein," PNAS, vol. 91, 418-22 (1994).
Matera, A.G. and Ward, D.C., "Nucleoplasmic Organization of Small Nuclear Ribonucleoproteins in Cultured Human Cells," J. Cell Biol., vol. 121, No. 4, 715-27 (1993).
Merriman, H. et al., "The Tissue-Specific Nuclear Matrix Protein, NMP-2, is a Member of the AML/CBF/PEBP2/Runt Domain Transcription Factor Family: Interactions with the Osteocalcin Gene Promoter," Biochemistry, vol. 34, 13125-32 (1995).
Meyers, S. et al., "AML-2 is a Potential Target for Transcriptional Regulation by the t(8;21) and t(12;21) Fusion Proteins in Acute Leukemia," Oncogene,, vol. 13, 303-12 (1996).
Meyers, S. et al., "Identification of AML-1 and the (8;21) Translocation Protein (AML-1/ETO) as Sequence-Specific DNA-Binding Proteins: the runt Homology Domain is Required for DNA Binding and Protein-Protein Interactions," Molecular and Cellular Biology, vol. 13, No. 10, 6336-45 (1993).
Meyers, S. et al., "The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation," Molecular and Cellular Biology, vol. 15, No. 4, 1974-82 (1995).
Mitani, K. et al., "Generation of the AML1-EVI-1 Fusion Gene in the t(3;21)(q26;q22) Causes Blastic Crisis in Chronic Myelocytic Leukemia," EMBOJ, vol. 13, No. 3, 504-10 (1994).
Miyoshi, H. et al., "Alternative Splicing and Genomic Structure of the AML1 Gene Involved in Acute Myeloid Leukemia," Nucl. Acids. Res., vol. 23, No. 14, 2762-9 (1995).
Miyoshi, H. et al., "t(8;21) Breakpoints of Chromosome 21 in Acute Myeloid Leukemia are Clustered Within a Limited Region of a Single Gene, AML1," PNAS, vol. 88, 10431-4 (1991).
Miyoshi, H. et al., "The t(8;21) Translocation in Acute Myeloid Leukemia Results in Production of
Hiebert Scott
Lawrence Jeanne
Lian Jane B.
Meyers Shari
Penman Sheldon
Mandragouras, Esq. Amy E.
McKelvey Terry
Remillard, Esq. Jane E.
St. Jude's Children's Research Hospital
University of Massachusetts
LandOfFree
Isolated nuclear matrix targeting peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nuclear matrix targeting peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nuclear matrix targeting peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726864